Bio

Dr. Mina has been widely recognized with numerous awards for his innovative efforts in healthcare during his career. Dr. Mina is a physician-scientist and executive leader with a focus at the intersection of biotechnology and data science, AI, healthcare product development, and regulation.

He completed post-doctoral fellowships at Princeton in Applied Math in Infectious Diseases and at Harvard Medical School in Genetics and Immune Engineering. He also completed a residency in Clinical Pathology at Harvard Mass General Brigham and held a faculty appointment as Assistant Professor of Epidemiology, Immunology and Pathology at Harvard Medical School and the Broad Institute. While in this capacity, Dr. Mina was the medical director for the Broad’s COVID-19 testing services and had a major impact in the field through those services as well as through his work in educating the emerging field on the appropriate role of antigen vs. PCR testing.

Expertise

Dr. Mina was most recently CSO and President Research and Public Health for eMed, a company focused on consumer centric testing solutions delivered with virtual medical supervision. He has served as a fractional CMO and BOD member for Quantum SI, a protein sequencing company, and a fractional CMO for Detect (at-home infectious diseases testing) and LivePerson (healthcare AI). Dr. Mina received his MD and PhD from Emory with a focus on Population Biology, Infectious Diseases and Evolution.